Wordt geladen...
Oral Apremilast for the Treatment of Plaque Psoriasis
This article provides an update on the use of oral apremilast, a phosphodiesterase-4 (PDE4) inhibitor, for the treatment of plaque psoriasis. Emphasis is placed on safety evaluations, although efficacy considerations are also addressed. Both two-year and three -year data analyses support the favorab...
Bewaard in:
| Gepubliceerd in: | J Clin Aesthet Dermatol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Matrix Medical Communications
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5110328/ https://ncbi.nlm.nih.gov/pubmed/27878061 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|